Oct 26 (Reuters) – Drug developers Aspen Neuroscience and Bambusa Therapeutics launched their US initial public offering roadshows on Monday, adding to a wave of issuers from the biotech industry that
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
De Minaur battles through, Mensik and Berrettini also advance in Vienna
VIDEO SHOWS: ATP 500 VIENNA OPEN FIRST ROUND HIGHLIGHTS SHOWS: VIENNA, AUSTRIA (OCTOBER 26, 2026)…
No. 17 Florida holds off naming QB1 with No. 3 Georgia up next
Florida coach Jon Sumrall is not declaring a starting quarterback early in the week as…
Skydance offers buyouts to some employees to cut costs after Warner Bros merger
Oct 26 (Reuters) - Skydance is offering some employees a one-time voluntary buyout, according to…
